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Background. Although end-stage renal disease (ESRD) has
been associated with accelerated vascular disease of the cere-
bral circulation, there are no prior studies that have estimated
the risk of hemorrhagic and ischemic stroke among the United
States dialysis population relative to the general population.
Methods. We performed a population-based cohort study
to compare rates of hospitalized ischemic and hemorrhagic
stroke among incident dialysis patients in the United States
Renal System database and non-ESRD subjects from the gen-
eral population identified in the National Hospital Discharge
Survey.
Results. After adjustment for age, gender, and race, esti-
mated rates of hospitalized stroke were markedly higher for
dialysis patients compared to the general population. The age-
adjusted relative risk (RR) of stroke among dialysis patients
compared to the general population was 6.1 [95% Confidence
Interval (95% CI) 5.1, 7.1] for Caucasian males, 4.4 (95% CI
3.3, 5.5) for African American males, 9.7 (95%CI 8.2, 11.2)
for Caucasians females and 6.2 (95%CI 4.8, 7.6) for African
American females. When considered as separate outcomes, hos-
pitalization rates for hemorrhagic and ischemic stroke were both
markedly elevated for subjects treated with dialysis (ischemic,
RR  4.3 to 10.1; hemorrhagic, RR  4.1 to 6.7).
Conclusion. Incident dialysis patients are at markedly higher
risk for hospitalized stroke when compared to the general
population. Although prior public health initiatives have fo-
cused primarily on cardiac disease among patients treated with
dialysis, our data suggest that new initiatives are needed to
control the high risk of stroke in this population.
Patients with end-stage renal disease (ESRD) have
markedly advanced vascular disease when compared to
the general population [1–12]. In particular, several au-
thors have reported more severe atherosclerotic disease
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of the carotid arteries among ESRD patients than in
subjects with normal renal function [3, 6–8, 12]. This
accelerated disease of the cerebral vasculature could in-
crease the risk of ischemic stroke in these patients. Addi-
tionally, ESRD is associated with hypertension, a bleed-
ing diathesis, and the routine administration of heparin
during hemodialysis, which could increase the risk of hem-
orrhagic stroke.
Despite an excess of subclinical cerebrovascular dis-
ease and stroke risk factors among ESRD patients, the
evidence for an excess risk of clinical stroke remains in-
conclusive. The only studies estimating the rate of stroke
in dialysis patients relative to the general population were
preformed in Japan [13–15]. These studies found an in-
creased risk of hemorrhagic stroke among dialysis pa-
tients compared to the general population, whereas rates
of ischemic stroke were equal to or lower than the gen-
eral population. However, caution must be taken in gen-
eralizing results from these studies since stroke rates in
the Japanese general population are different from those
in the United States [16]. Further, the Japanese dialysis
population tends to be younger and has fewer comorbid
illnesses than the dialysis population in the United States
[17]. Similar studies have not been conducted in the
United States dialysis population. In this report, we used
data from the United States Renal Data System (USRDS)
and the National Hospital Discharge Survey (NHDS)
to compare the risk of hospitalized stroke between the
dialysis and general populations of the United States. We
hypothesized that patients treated with dialysis are at much
higher risk for both ischemic and hemorrhagic stroke.
METHODS
Data sources/subject population
General population. We used data from the 1996
NHDS to determine stroke hospitalization rates among
the general population. Details of the NHDS are de-
scribed elsewhere [18]. Briefly, the NHDS is a national
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probability survey of non-Federal short-stay hospital dis-
charges, conducted annually by the National Center for
Health Statistics (NCHS). In 1996, the NHDS used a
three-stage sampling system, resulting in a sample of over
250,000 nonnewborn hospitalizations at 490 hospitals.
Information was collected on basic patient demograph-
ics, type of facility, and up to seven discharge diagnoses.
Because population estimates for specific racial groups
other than Caucasian or African Americans were not
available for 1996, we restricted our analysis to Cauca-
sians and African Americans only. We excluded individ-
uals younger than 18 years of age, who were not at appre-
ciable risk of stroke, and individuals older than 100 years
of age, as well as subjects with missing race, age, or
gender. Stroke hospitalizations were also excluded for
subjects with coexistent ESRD, defined by the presence
of an International Classification of Diseases-9th revi-
sion, Clinical Modification (ICD-9-CM) discharge diag-
nosis code of 585 during the same discharge at which
the stroke occurred. Sampling weights provided with the
dataset were applied to each hospitalization to extrapo-
late the survey results to the entire United States popula-
tion.
ESRD population. Data on ESRD patients were ob-
tained from the USRDS. Details of the studies per-
formed by the USRDS are described elsewhere [19].
Briefly, the USRDS collects demographic and clinical
data on all patients who have survived more than 90
days while undergoing care for ESRD. Hospitalizations
of individual USRDS subjects were identified from Medi-
care claims records linked to subjects through unique
identifiers assigned by the USRDS. For this analysis, all
subjects in the USRDS database who were described as
Caucasian or African American and who were beginning
chronic hemodialysis or peritoneal dialysis from 1993
through 1998 were considered eligible for inclusion into
the cohort. The choice of this time period was motivated
by the fact that after 1992 the ICD-9-CM diagnosis codes
for stroke were revised to allow for greater distinction
between ischemic stroke and other cerebrovascular con-
ditions. To conform with the eligibility criteria described
above within the NHDS database, we excluded subjects
of non-Caucasian, non-African American races, and sub-
jects younger than 18 years or older than 100 years. We
also excluded subjects with missing data for age, gender,
or race, and those subjects who received a renal trans-
plant prior to initiating dialysis.
Outcome definition
For both the USRDS and NHDS datasets, stroke hos-
pitalization was defined as a hospitalization in which one
of the discharge diagnoses (either primary or up to six
secondary diagnoses) was ischemic or hemorrhagic
stroke, as defined by ICD-9-CM diagnosis codes. Based
on prior reports of the accuracies of the nine ICD-9-CM
codes for stroke (430 to 438) in identifying true acute
stroke hospitalizations [20–25], the following five codes
were chosen a priori to identify acute stroke in this study:
430 (subarachnoid hemorrhage), 431 (intracerebral hem-
orrhage), 433.X1 (occlusion of precerebral arteries with
infarction), 434.X1 (occlusion of cerebral arteries with
infarction), and 436 (acute cerebrovascular attack), where
“X” can be any integer from 0 to 9. In secondary analyses,
we considered hospitalizations for hemorrhagic (430 and
431) and ischemic stroke (433.X1, 434.X1, and 436) to
be separate outcomes, as well as only hospitalizations
with a primary discharge diagnosis of stroke (excluding
cases where the stroke ICD-9-CM code occurred in any
of the six secondary positions). Since the NHDS database
does not feature a method to identify individual subjects,
it is not possible to distinguish hospitalizations for an
incident stroke versus a recurrent stroke for a given
individual in the survey. Therefore, in order to ensure
a meaningful comparison of the estimated stroke rates
for the dialysis and general populations, we also counted
both first and recurrent stroke hospitalizations for each
subject in the USRDS cohort.
Statistical methods
Due to the survey methods used to collect NHDS data,
individual patient time is not available. Therefore, the
prevalent population was assumed to be at risk for hospi-
talized stroke for the entire year in 1996. For the pur-
poses of this study, we defined the at-risk population as
the point-prevalent Caucasian and African American
adult (18 years and100 years) United States popula-
tion on July 1, 1996, as estimated by the United States
Census Bureau. This information was provided with the
NHDS database. For subjects in the USRDS database,
time at risk for stroke was defined as the time from
initiation of dialysis (on the basis of the first billing claim
for dialysis treatment) until death, transplantation, loss
to follow-up, or end of study (December 31, 1998).
The rates of stroke hospitalization were calculated
for both dialysis patients and the general population by
dividing the number of stroke hospitalizations by the
total person time at risk, stratified by age, gender, and
race. Robust standard errors of the stroke rates for the
USRDS population were computed using Poisson re-
gression models, taking into account the clustered nature
of the data. Robust standard errors of stroke rates from
the NHDS dataset were computed according to instruc-
tions provided with the dataset.
Two types of measurements were used to describe
differences in stroke rates between the ESRD and gen-
eral populations. First, the difference in rates of hospital-
ized stroke between the dialysis and general populations
was computed for each age-, race-, and gender-specific
subgroup. This rate difference, referred to as the attribut-
able risk, represents the excess rate of stroke in the
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ESRD population beyond what would be expected from
the “background rate” in the general population. In addi-
tion, race- and gender-specific relative risks (RR) for
the dialysis vs. general population were computed after
internal standardization for age. Standard errors of esti-
mated relative risks were computed under the assump-
tion that estimates of the rate of stroke hospitalization in
each comparison group were independent and normally
distributed. Data abstraction was performed with SAS
version 8.2 software (SAS Institute, Cary, NC, USA)
and statistical analyses were performed using Stata ver-
sion 7.0 (Stata Corporation, College Station, TX, USA).
Sensitivity analyses. We performed two sensitivity
analyses to assess the robustness of our results to differ-
ent assumptions regarding person time and missing data.
In the first sensitivity analyses, we sought to determine
whether our primary results were potentially influenced
by the different methods used to calculate person time
for the general population (where we assumed each per-
son was at risk for an entire year) and the dialysis popula-
tion (where we determined exact time at risk for each
subject). In this analysis, we used identical methods to
calculate person time for each population assuming that
the incident dialysis population, like the general popula-
tion, was at risk for stroke hospitalization for 1 year,
regardless of their actual mortality and loss to follow-
up, and included stroke hospitalizations occurring within
this 1-year period. In a second sensitivity analysis, we
sought to determine the potential effect of missing race
data in the NHDS on our primary results. Rather than
excluding strokes occurring in subjects with missing or
unknown race in the NHDS dataset (as in the primary
analysis), we assumed that 85% of these subjects were
Caucasian, and the remainder were African Americans;
this assumption was based on a prior analysis by the
NCHS, which suggested that most of the subjects with
unknown race (85%) were actually Caucasian [26].
RESULTS
A total of 436,000 adult incident hemodialysis and
peritoneal dialysis patients from 1993 through 1998 were
identified from the USRDS. Of these, 4789 (1.1%) had
an unknown or unreported race, and 27,498 (6.3%) were
neither Caucasian nor African American, resulting in a
final sample of 404,226 subjects. These subjects contrib-
uted 670,651 years of at-risk person time, during which
25,560 individual subjects experienced a total of 32,151
stroke hospitalizations, yielding an unadjusted stroke
hospitalization rate of 479.4 strokes per 10,000 person-
years. Of the 32,151 recorded stroke hospitalizations,
3395 (10.6%) were for hemorrhagic stroke.
A total of 5563 sampled stroke hospitalizations among
adults were identified in the NHDS survey. Of these, 60
(1.1%) were in subjects with coexistent chronic renal
Fig. 1. Excess rate of stroke hospitalization in end-stage renal disease
(ESRD) patients compared to the general population (per 10,000 person-
years).
failure and were excluded from further analysis. Of the
remaining 5503 unweighted stroke hospitalizations in the
survey, 1275 (23.2%) occurred in subjects with unre-
ported or unknown race, while 297 (5.4%) occurred in
non-Caucasian, non-African American subjects, and these
strokes were excluded from the primary analysis. Those
subjects whose strokes were excluded because of missing
race were of similar age compared to those subjects
whose strokes were included in the analysis (mean age,
72.0 versus 72.4 years) and were equally likely to be male
(54.3% versus 56.4%).
After appropriate sampling weights were applied, the
resulting 3930 stroke hospitalizations in the survey were
extrapolated to provide an estimate of 540,565 total stroke
hospitalizations in the entire adult United States Cauca-
sian and African American non-ESRD population dur-
ing the year 1996. Of the estimated 540,565 stroke hospi-
talizations, 79,716 (14.7%) were coded as hemorrhagic
stroke. Using the estimated adult Caucasian and African
American United States population in 1996 as the popu-
lation at risk, the unadjusted total stroke hospitalization
rate for the general population was estimated to be 29
per 10,000 person-years.
Stroke hospitalization rates for ESRD patients were
markedly higher than in the general population among
both males and females in every age group and for both
Caucasians and African Americans. The excess risk of
hospitalized stroke attributable to ESRD (Fig. 1) ranged
from 81.4 strokes per 10,000 person-years (for young
African American males) to 880 strokes per 10,000 per-
son years (for older Caucasian females). The magnitude
of excess risk attributable to ESRD was greatest for
older subjects, females, and Caucasians.
Age-standardized relative risks of hospitalized stroke
for ESRD patients compared to the general population
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Table 1. Stroke hospitalization rates among dialysis patients versus the general population
Dialysis populationa General populationb
Number of Person time Hospital Number of Person time Hospital Age-adjusted
Race Gender strokes years ratec strokes years ratec RRd
Caucasian Male 9,851 228,767 430.6 201,856 79,055,576 25.5 6.1 (5.1, 7.1)
Female 11,033 185,944 593.4 253,901 84,981,650 29.9 9.7 (8.2, 11.2)
African American Male 3,904 123,654 315.7 33,816 10,263,667 32.9 4.4 (3.3, 5.5)
Female 7,363 132,287 575.6 50,992 12,276,417 41.5 6.2 (4.8, 7.6)
aIncident hemodialysis and peritoneal dialysis patients in the United States Renal Data System (USRDS) database from 1993 to 1998
bData from the 1996 National Hospital Discharge Survey, excluding subjects with coexistent chronic renal failure
cRate of stroke hospitalizations per 10,000 person-years
dRate ratios are age-adjusted, using the race- and gender-specific dialysis population as the reference standard.
Table 2. Stroke hospitalization rate ratios among dialysis patients versus the general population: Secondary outcomes
Age-adjusted stroke rate ratios
Race Gender Stroke as primary diagnosisa Hemorrhagic strokeb Ischemic strokec
Caucasian Males 4.9 (4.2, 5.6) 5.9 (4.3, 7.6) 6.1 (5.1, 7.1)
Females 8.0 (6.9, 9.1) 6.7 (5.0, 8.3) 10.1 (8.5, 11.7)
African American Males 3.5 (2.6, 4.4) 4.1 (1.9, 6.2) 4.3 (3.2, 5.5)
Females 5.0 (3.8, 6.2) 4.0 (2.2, 5.7) 6.5 (5.0, 8.1)
a Hospitalizations in which stroke (hemorrhagic or ischemic) is the primary (first listed) diagnosis
b Stroke hospitalizations with International Classification of Diseases–9th revision–Clinical Modification (ICD-9-CM) diagnosis codes 430 or 431 in the primary
or secondary positions
c Stroke hospitalizations with ICD-9-CM diagnosis codes 433.X1, 434.X1, or 436 in the primary or secondary positions
are shown for Table 1. Among males, the relative risk
was estimated to be 6.1 (95% CI 5.1, 7.1) for Caucasians
and 4.4 (95% CI 3.3, 5.5) for African Americans. The
age-standardized risk of stroke hospitalization for female
ESRD patients was estimated to be 9.7-fold higher (95%
CI 8.2, 11.2) for Caucasians and 6.2-fold higher (95%
CI 4.8, 7.6) for African Americans when compared to
females in the general population. When only hospital-
izations with a primary discharge diagnosis of stroke
were considered (Table 2), the rate of hospitalization
remained markedly higher for dialysis patients for both
male (Caucasian, RR  4.9, 95% CI  4.2, 5.6; African
American, RR  3.5, 95% CI  2.6, 4.4) and female
(Caucasian, RR 8.0, 95% CI 6.9, 9.1; African Ameri-
can RR  5.0, 95% CI  3.8, 6.2) dialysis patients.
Hospitalization rates separated for hemorrhagic and
ischemic stroke were also elevated in dialysis patients
compared to the general population (Table 2), although
the magnitude of this excess stroke risk was greater for
ischemic stroke (RR, 4.3 to 10.1) than hemorrhagic
stroke (RR, 4.1 to 6.7).
Sensitivity analyses were conducted to assess whether
our findings were dependent upon a particular method
of calculating person time. After assuming that each
dialysis subject was at risk for stroke for an entire year,
regardless of the subject’s actual mortality or loss to
follow-up, rates of hospitalization for dialysis patients
were still greatly increased compared to the general pop-
ulation (Caucasian males, RR  4.9; African American
males, RR  3.5; Caucasian females, RR  7.6; African
American females, RR  5.2). In another sensitivity
analysis, we assessed whether our findings were depen-
dent on the degree of missing data for race in the NHDS
dataset. We assumed that 85% of the strokes in subjects
of unknown race occurred in Caucasian subjects, and
that the remaining 15% occurred in African American
subjects, and did not exclude these strokes from the
analysis. Under this assumption, the stroke rate ratios
were not markedly changed for either Caucasians (males,
RR  4.8; females, RR  7.7) or African Americans
(males, RR  3.4; females, RR  5.1). Even if one
assumes that only 50% of the subjects with unknown
race are Caucasian or that all of the subjects with un-
known race are Caucasian (both highly unlikely scenar-
ios), ESRD subjects of both races and sexes are still at
markedly higher risk of stroke (data not shown).
DISCUSSION
We compared rates of stroke hospitalization among
the incident dialysis population to the non-ESRD gen-
eral population. After adjustment for age and gender,
we found that incident dialysis patients experienced five-
to tenfold higher rates of hospitalized stroke when com-
pared to non-ESRD subjects. The relative risk of stroke
was higher for Caucasian than for African American
patients, and was higher for women. Although stroke
rates were markedly elevated among dialysis patients
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for both ischemic and hemorrhagic stroke, the excess
risk attributable to ESRD was somewhat greater for
ischemic stroke than for hemorrhagic stroke, especially
among women.
Our finding of an excess risk of hemorrhagic stroke is
in agreement with previous studies conducted in Japa-
nese dialysis patients, in whom the risk was three to ten
times greater than in the general population [14, 15, 27].
However, we also found strong evidence for an increased
risk of ischemic stroke associated with ESRD. This is in
contrast to two of the studies in the Japanese dialysis
population, in which the risk of ischemic stroke was
found to be either lower than or equal to the risk in the
general population [14, 27]. Although a third study from
the Japanese dialysis population found a roughly four-
fold increase in the risk of ischemic stroke [15], this study
did not adjust for differences in age between the dialysis
and general populations, making interpretation difficult.
Several explanations exist for the differences in our find-
ings compared to prior studies in the Japanese dialysis
population. While the authors of the Japanese studies
validated the types of strokes through medical record
review, our study used ICD-9-CM diagnosis codes, which
may have resulted in some misclassification of stroke
type. However, the proportion of hemorrhagic strokes
in the general population in our study (15%) is roughly
similar to the proportion observed in prior United States
studies in which the stroke subtype was validated [20,
28, 29], suggesting that stroke types in our study were not
greatly misclassified. In addition, because the Japanese
studies included only hemodialysis patients, whereas the
current study included both hemodialysis and peritoneal
dialysis patients, comparisons between studies may not
be accurate. However, as less than 10% of incident dial-
ysis patients are on peritoneal dialysis [30], this small
difference in treatment modalities is unlikely to explain
the discrepant results. Alternatively, the different results
may be due to greater rates of atherosclerotic risk factors
(e.g., diabetes, prevalent cardiac disease) among United
States compared to the Japanese dialysis population [17],
which could result in a higher relative risk of ischemic
stroke for the United States dialysis patients than for
their Japanese counterparts.
There are a number of possible explanations for the
excess risk of stroke we observed among dialysis patients.
Studies by Muntner et al [31] and Longnecker et al [32]
have demonstrated that traditional stroke risk factors,
such as diabetes, hypertension, cardiac disease, and prior
stroke, are much more common among the dialysis popu-
lation than in the general population. However, it seems
unlikely that the enormously higher risk of stroke ob-
served in the ESRD population is explained purely by
differences in stroke risk factor prevalences. An addi-
tional factor responsible for the higher stroke rates may
be accelerated atherosclerotic vascular disease caused in
part by uremia itself. This is supported by reports using
noninvasive imaging techniques, demonstrating a greater
degree of carotid artery atherosclerosis among dialysis
patients compared to controls subjects, even after ad-
justing for traditional cardiovascular risk factors [3, 6–8,
12]. In addition to this accelerated vascular disease, other
dialysis-specific factors could increase the risk of stroke
for ESRD patients. The sudden decreases in systemic
blood pressure caused by hemodialysis could cause a
reduction in cerebral perfusion, leading to ischemic stroke.
Finally, the routine anticoagulation during hemodialysis,
combined with a uremic bleeding diathesis, could lead
to an increased risk of hemorrhagic stroke.
The excess risk of stroke attributable to ESRD was
greater for Caucasians than for African American sub-
jects and greater for female than for male subjects (Fig.
1). The reason for these differences is unclear, but it
is possible that racial and gender discrepancies in the
prevalence of atherosclerotic disease and other stroke
risk factors are different for individuals with and without
renal failure. Further study is necessary to clarify differ-
ences in the risk of stroke attributable to ESRD across
race and gender.
There are several limitations of this study. First, valida-
tion of stroke hospitalizations was not possible in the data
sources available for this study, since such validation would
have been logistically unreasonable in study populations
of this size. However, the combination of ICD-9-CM
codes used to identify strokes in our study has been shown
to have high sensitivity and specificity in identifying true
stroke hospitalizations in the general population [25].
In addition, one would expect any misclassification of
outcome to occur equally in both the ESRD and general
populations. Such nondifferential misclassification would
only result in an underestimate of the true relative risk
of stroke among ESRD subjects.
A similar misclassification may have occurred with
regard to identification and exclusion of stroke hospital-
izations for subjects in the NHDS database who also had
coexistent ESRD. The accuracy of the diagnosis code
for ESRD (code 585) has not been validated, and it is
likely that some individuals with ESRD remained in our
referent general population despite attempts to exclude
them. However, such misclassification would again result
in an underestimate of the true excess stroke risk for
the ESRD population.
The stroke rates presented in this report represent
both first and recurrent strokes, since the NHDS study
does not distinguish between these events. Therefore,
the excess stroke risk observed in the ESRD patients in
this study may differ from the risk of incident or first
stroke, especially if the proportion of recurrent strokes
differs markedly among the ESRD and general popula-
tions. However, we estimated that about 15% to 20%
of strokes in dialysis patients represent recurrent rather
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than first strokes, a proportion similar to that reported
among the general population [33]. Therefore, it is likely
that the relative risk of incident stroke in dialysis patients
is similar to relative risk of total stroke presented in this
report.
Another potential limitation of the current study is
the absence of individual person time data for the general
population. Instead, we assumed that the point-prevalent
population of mid-1996 was at risk for an entire year.
Although this is an accepted method of estimating per-
son time for large populations, the actual person time
at risk may have been overestimated in our analysis,
biasing toward lower estimates of stroke rates in the
general population. However, our sensitivity analysis
suggests that our results are not significantly influenced
by the particular method of calculating person time. An
additional limitation is the degree of missing data on race
in the NHDS dataset. Again, the results of sensitivity
analyses suggested that missing race data did not lead
to significantly different point estimates in our main anal-
ysis. Despite these limitations, this is the first study to
determine the risk of stroke among the United States
dialysis population relative to the non-ESRD popula-
tion. In addition, since the study cohort includes nearly
all incident dialysis patients in the United States rather
than a regional sample, these results are generalizable
to the United States dialysis population as a whole.
CONCLUSION
Our results indicate that incident dialysis patients are
at five to ten times the risk of hospitalized stroke when
compared to patients without renal failure. Although
this high rate of stroke may not be unexpected given the
accelerated risk of atherosclerosis among ESRD pa-
tients, previous public health initiatives have focused
primarily on controlling cardiac disease among dialysis
patients [34]; our results suggest that similar initiatives
are needed to control the high risk of stroke in this pop-
ulation.
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